HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Indonesia to issue compulsory licenses for HIV, hepatitis B drugs still under patent

"The Indonesian government hopes to implement one of the largest ever examples of 'compulsory licensing,' which will enable the generic manufacture of drugs still under patent," IRIN reports.

27 Mar 2013

First multi-gene DNA sequencing test launched for cancer patients

The first multi-gene DNA sequencing test that can help predict cancer patients' responses to treatment has been launched in the National Health Service, thanks to a partnership between scientists at the University of Oxford and Oxford University Hospitals NHS Trust.

26 Mar 2013

New Frontiers in Public Health journal launched

Frontiers, one of the world's fastest-growing Open Access publishers and among the largest social networking platforms for researchers, announces the launch of a new journal, Frontiers in Public Health.

22 Mar 2013

Male circumcision a 'staggeringly under-utilized tool'

"PrePex, the new nonsurgical circumcision tool experts believe could revolutionize the prevention of HIV and AIDS in sub-Saharan Africa, is easier to assemble than a toy you might find in a Happy Meal," freelance journalist Patrick Adams writes in the New York Times' "Opinionator" blog.

22 Mar 2013

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

30 years into the HIV epidemic, there is no vaccine in sight. Yet, even though there are fantastic and effective cheap and universally available drugs, and a treatment as prevention strategy is known to work, people do not wish to get tested for HIV! If everyone got tested, and treated, we could have brought the infection under control a long time ago!

21 Mar 2013

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

Affinium Pharmaceuticals announced today that its Phase 2a clinical trial evaluating oral AFN-1252 in acute bacterial skin & skin structure infections demonstrated excellent efficacy and safety data, marking a significant proof-of-concept milestone for Affinium's first-in-class, novel antibiotic targeted against bacterial fatty acid biosynthesis inhibition (FabI inhibitors).

21 Mar 2013

More action needed to fight TB, as drug resistance spreading

"As we mark World [Tuberculosis (TB)] Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat -- one that must be urgently addressed," John Lechleiter, chair, president and CEO of Eli Lilly and Company and chair of the board of PhRMA, writes in a Forbes opinion piece, adding, "With resistance spreading, we need a renewed global commitment that combines public and private efforts to defeat TB."

21 Mar 2013

Hepatitis C and HIV co-infection treatment: an interview with Prof Boecher, Boehringer Ingelheim

Chronic hepatitis C infection is one of the most frequent chronic infectious diseases worldwide. The WHO estimates that 150 million people worldwide are chronically infected with the hepatitis C virus (HCV).

20 Mar 2013

New Alzheimer's data highlight the disease's deadly toll

According to figures released by the Alzheimer's Association, deaths from Alzheimer's and other forms of dementia rose 68 percent between 2000 and 2010.

20 Mar 2013

Hepatitis C virus rarely transmitted through sex between monogamous heterosexuals

Individuals infected by the hepatitis C virus (HCV) have nothing to fear from sex in a monogamous, heterosexual relationship. Transmission of HCV from an infected partner during sex is rare according to new research published in the March issue of Hepatology, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD).

19 Mar 2013

New report shows Alzheimer's deaths continue to rise in US

According to the Alzheimer's Association 2013 Alzheimer's Disease Facts & Figures report released today, one in three seniors dies with Alzheimer's or another dementia in the United States.

19 Mar 2013

First Edition: March 19, 2013

Today's headlines include coverage of a new report about the troubling reach of Alzheimer's disease.

19 Mar 2013

Mylan gets final approval from FDA for generic Xopenex Inhalation Solution

Mylan Inc. today announced that its subsidiary Mylan Specialty L.P. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levalbuterol Inhalation Solution USP, 0.31 mg/3 mL (0.0103%), 0.63 mg/3 mL (0.021%), and 1.25 mg/3 mL (0.042%), (Concentrate).

19 Mar 2013

Study shows widespread use of antiretroviral drugs would increase prevalence of MDR HIV

One of the most widely advocated strategies for dealing with HIV/AIDS could double the number of multi-drug-resistant HIV cases in the population of men who have sex with men in LA County over the next 10 years, cautions a new study.

19 Mar 2013

Measuring HIV programs' impacts will improve return on investment, 'drive better performance'

Noting that Bill Gates, co-chair of the Bill & Melinda Gates Foundation, in his annual letter "argued that it is essential to carefully measure progress in innovation and global health," Stefano Bertozzi, director of HIV at the Gates Foundation, writes in a SciDev.Net opinion piece, "This is because while measuring the quantity of interventions is important, we also need to determine which interventions -- and which approaches to them -- create the greatest long-term impact."

16 Mar 2013

CSIS report examines U.S., South Africa efforts to transition HIV/AIDS programming

The Center for Strategic & International Studies on Thursday released a report, titled "The Future of the U.S.-South Africa HIV/AIDS Partnership," examining the joint U.S.-South Africa effort "to transition responsibility for HIV/AIDS programming and policies to the South African government," the center reports on its webpage.

16 Mar 2013

ABC News examines how newly selected Pope's stance on contraception might impact Catholic organizations working on HIV/AIDS

ABC News examines how the selection of Cardinal Jorge Bergoglio of Argentina to be Pope might impact Catholic organizations' work in disease prevention, including HIV/AIDS prevention.

16 Mar 2013

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.

14 Mar 2013

Implications of IOM PEPFAR evaluation for Global Fund

"The U.S. Institute of Medicine of the National Academy of Sciences recently completed a congressionally mandated impact evaluation of the PEPFAR HIV/AIDS program, which is the single largest ever health initiative of the U.S. government," Todd Summers, senior adviser at the Center for Strategic & International Studies' (CSIS) Global Health Policy Center, writes in the center's "Smart Global Health" blog.

13 Mar 2013

Recently employees from SCCA and Fred Hutch receive health care awards

Recently employees from both Fred Hutchinson Cancer Research Center (Fred Hutch) and Seattle Cancer Care Alliance (SCCA) were recognized with industry awards for being leading innovators in health care.

13 Mar 2013

HIV/AIDS News and Research

Further Reading

Indonesia to issue compulsory licenses for HIV, hepatitis B drugs still under patent

First multi-gene DNA sequencing test launched for cancer patients

New Frontiers in Public Health journal launched

Male circumcision a 'staggeringly under-utilized tool'

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

More action needed to fight TB, as drug resistance spreading

Hepatitis C and HIV co-infection treatment: an interview with Prof Boecher, Boehringer Ingelheim

New Alzheimer's data highlight the disease's deadly toll

Hepatitis C virus rarely transmitted through sex between monogamous heterosexuals

New report shows Alzheimer's deaths continue to rise in US

First Edition: March 19, 2013

Mylan gets final approval from FDA for generic Xopenex Inhalation Solution

Study shows widespread use of antiretroviral drugs would increase prevalence of MDR HIV

Measuring HIV programs' impacts will improve return on investment, 'drive better performance'

CSIS report examines U.S., South Africa efforts to transition HIV/AIDS programming

ABC News examines how newly selected Pope's stance on contraception might impact Catholic organizations working on HIV/AIDS

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Implications of IOM PEPFAR evaluation for Global Fund

Recently employees from SCCA and Fred Hutch receive health care awards

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News